VIRAL UPPER RESPIRATORY TRACT INFECTION

This adverse event was reported 4758 times

These drugs are most commonly taken by patients reporting VIRAL UPPER RESPIRATORY TRACT INFECTION:

# Drug Count
0 ETANERCEPT 564
1 METHOTREXATE SODIUM 432
2 METHOTREXATE 401
3 ADALIMUMAB 368
4 PREDNISONE 357
5 ACETAMINOPHEN 243
6 ERGOCALCIFEROL 237
7 TOFACITINIB 219
8 HYDROXYCHLOROQUINE SULFATE 214
9 ALBUTEROL SULFATE 207
See all common drugs associated with VIRAL UPPER RESPIRATORY TRACT INFECTION

VIRAL UPPER RESPIRATORY TRACT INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GOLD 79 0.0136
1 ERGOCALCIFEROL 237 0.0080
2 METHYLPREDNISOLONE ACETATE 64 0.0079
3 GOLIMUMAB 87 0.0069
4 INFLIXIMAB-DYYB 19 0.0055
5 ONASEMNOGENE ABEPARVOVEC-XIOI 12 0.0052
6 PSYLLIUM HUSK 7 0.0052
7 AMOXICILLIN AND CLAVULANATE POTASSIUM 17 0.0037
8 IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE 11 0.0027
9 CLINDAMYCIN PHOSPHATE 13 0.0024
See all drugs enriched for association with VIRAL UPPER RESPIRATORY TRACT INFECTION

VIRAL UPPER RESPIRATORY TRACT INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 72 0.1047
1 Provitamin D2 Compound [EPC] 237 0.0080
2 CD38-directed Cytolytic Antibody [EPC] 25 0.0043
3 Interleukin-17A Antagonist [EPC] 108 0.0029
4 Guanylate Cyclase-C Agonist [EPC] 6 0.0029
5 PCSK9 Inhibitor [EPC] 70 0.0027
6 Human Immunoglobulin G [EPC] 55 0.0026
7 Autologous Cellular Immunotherapy [EPC] 12 0.0021
8 Oxytocic [EPC] 6 0.0020
9 Antisense Oligonucleotide [EPC] 22 0.0018
See all drug classes enriched for association with VIRAL UPPER RESPIRATORY TRACT INFECTION